Patient Safety Organizations: Voluntary Relinquishment for the Chicago Breast Cancer Quality Consortium

Published date28 September 2021
Citation86 FR 53658
Record Number2021-21072
SectionNotices
CourtAgency For Healthcare Research And Quality
Federal Register, Volume 86 Issue 185 (Tuesday, September 28, 2021)
[Federal Register Volume 86, Number 185 (Tuesday, September 28, 2021)]
                [Notices]
                [Pages 53658-53659]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2021-21072]
                =======================================================================
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                Agency for Healthcare Research and Quality
                Patient Safety Organizations: Voluntary Relinquishment for the
                Chicago Breast Cancer Quality Consortium
                AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department
                of Health and Human Services (HHS).
                ACTION: Notice of delisting.
                -----------------------------------------------------------------------
                SUMMARY: The Patient Safety and Quality Improvement Final Rule (Patient
                Safety Rule) authorizes AHRQ, on behalf of the Secretary of HHS, to
                list as a patient safety organization (PSO) an entity that attests that
                it meets the statutory and regulatory requirements for listing. A PSO
                can be ``delisted'' by the Secretary if it is found to no longer meet
                the requirements of the Patient Safety and Quality Improvement Act of
                2005 (Patient Safety Act) and Patient Safety Rule, when a PSO chooses
                to voluntarily relinquish its status as a PSO for any reason, or when a
                PSO's listing expires. AHRQ accepted a notification of proposed
                voluntary relinquishment from the Chicago Breast Cancer Quality
                Consortium, PSO number P0074, of its status as a PSO, and has delisted
                the PSO accordingly.
                DATES: The delisting was effective at 12:00 Midnight ET (2400) on
                September 14, 2021.
                ADDRESSES: The directories for both listed and delisted PSOs are
                ongoing and reviewed weekly by AHRQ. Both directories can be accessed
                electronically at the following HHS website: http://www.pso.ahrq.gov/listed.
                FOR FURTHER INFORMATION CONTACT: Cathryn Bach, Center for Quality
                Improvement and Patient Safety, AHRQ, 5600 Fishers Lane, MS 06N100B,
                Rockville, MD 20857; Telephone (toll free): (866) 403-3697; Telephone
                (local): (301) 427-1111; TTY (toll free): (866) 438-7231; TTY (local):
                (301) 427-1130; Email: [email protected].
                SUPPLEMENTARY INFORMATION:
                [[Page 53659]]
                Background
                 The Patient Safety Act, 42 U.S.C. 299b-21 to 299b-26, and the
                related Patient Safety Rule, 42 CFR part 3, published in the Federal
                Register on November 21, 2008 (73 FR 70732-70814), establish a
                framework by which individuals and entities that meet the definition of
                provider in the Patient Safety Rule may voluntarily report information
                to PSOs listed by AHRQ, on a privileged and confidential basis, for the
                aggregation and analysis of patient safety work product.
                 The Patient Safety Act authorizes the listing of PSOs, which are
                entities or component organizations whose mission and primary activity
                are to conduct activities to improve patient safety and the quality of
                health care delivery.
                 HHS issued the Patient Safety Rule to implement the Patient Safety
                Act. AHRQ administers the provisions of the Patient Safety Act and
                Patient Safety Rule relating to the listing and operation of PSOs. The
                Patient Safety Rule authorizes AHRQ to list as a PSO an entity that
                attests that it meets the statutory and regulatory requirements for
                listing. A PSO can be ``delisted'' if it is found to no longer meet the
                requirements of the Patient Safety Act and Patient Safety Rule, when a
                PSO chooses to voluntarily relinquish its status as a PSO for any
                reason, or when a PSO's listing expires. Section 3.108(d) of the
                Patient Safety Rule requires AHRQ to provide public notice when it
                removes an organization from the list of PSOs.
                 AHRQ has accepted a notification of proposed voluntary
                relinquishment from the Chicago Breast Cancer Quality Consortium to
                voluntarily relinquish its status as a PSO. Accordingly, the Chicago
                Breast Cancer Quality Consortium, P0074, was delisted effective at
                12:00 Midnight ET (2400) on September 14, 2021.
                 Chicago Breast Cancer Quality Consortium has patient safety work
                product (PSWP) in its possession. The PSO will meet the requirements of
                section 3.108(c)(2)(i) of the Patient Safety Rule regarding
                notification to providers that have reported to the PSO and of section
                3.108(c)(2)(ii) regarding disposition of PSWP consistent with section
                3.108(b)(3). According to section 3.108(b)(3) of the Patient Safety
                Rule, the PSO has 90 days from the effective date of delisting and
                revocation to complete the disposition of PSWP that is currently in the
                PSO's possession.
                 More information on PSOs can be obtained through AHRQ's PSO website
                at http://www.pso.ahrq.gov.
                 Dated: September 23, 2021.
                Marquita Cullom,
                Associate Director.
                [FR Doc. 2021-21072 Filed 9-27-21; 8:45 am]
                BILLING CODE 4160-90-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT